Protocol for the CONVERT trial—Concurrent ONce-daily VErsus twice-daily RadioTherapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status

Publication | Open Access

DOI Full Paper Access

Citations

References

2016

Year

Corinne Faivre‐Finn, S. Falk, Linda Ashcroft, M. Bewley, Paul Lorigan, Elena Wilson, N. Groom, M. Snee, P. Fournel, Felipe Cardenal,

BMJ Open

Abstract

References